Drug shortages and pricing instability on generic injectables continue to burden healthcare providers and the patients they serve. HealthTrust is pleased to announce innovative Supply Interruption Mitigation Strategies (SIMS) to create stability and improve predictability around the supply of medications deemed critical to patient care. “In a global economy, understanding the intricate supply chains of […]
How can we assist you?
*“New technology” is classified as a product that, as compared to existing products:
- Offers significant technological advancements,
- Improves clinical outcomes or patient care in a significant way (i.e., documented reduction in procedure times, outcomes, lengths of stay, readmissions, infection rates), or
- Streamlines work processes and/or the economics of facility operations in a significant way (i.e., increase or decrease expenses in supply chain or resource utilization).
Demonstration of the above through independent, peer-reviewed publication(s) is beneficial, but not required.*
Get recent industry best-practice articles and insights from HealthTrust.